Credit Suisse’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $5.96M | Sell |
562,172
-120,146
| -18% | -$1.05M | 0.01% | 1195 |
|
|
2023
Q4 | $5.47M | Buy |
682,318
+105,748
| +18% | +$770K | 0.01% | 1282 |
|
|
2023
Q3 | $4.74M | Buy |
576,570
+10,041
| +2% | +$86.6K | ﹤0.01% | 1299 |
|
|
2023
Q2 | $4.53M | Buy |
566,529
+92,649
| +20% | +$683K | ﹤0.01% | 1403 |
|
|
2023
Q1 | $3.84M | Buy |
473,880
+26,671
| +6% | +$214K | ﹤0.01% | 1490 |
|
|
2022
Q4 | $2.81M | Sell |
447,209
-54,326
| -11% | -$379K | ﹤0.01% | 1689 |
|
|
2022
Q3 | $3.46M | Sell |
501,535
-49,831
| -9% | -$346K | ﹤0.01% | 1486 |
|
|
2022
Q2 | $4.61M | Buy |
551,366
+157,870
| +40% | +$2.21M | ﹤0.01% | 1332 |
|
|
2022
Q1 | $8.99M | Sell |
393,496
-29,489
| -7% | -$721K | 0.01% | 1090 |
|
|
2021
Q4 | $11.7M | Sell |
422,985
-10,870
| -3% | -$291K | 0.01% | 1387 |
|
|
2021
Q3 | $12.1M | Sell |
433,855
-194,382
| -31% | -$5.51M | 0.01% | 1409 |
|
|
2021
Q2 | $18.3M | Buy |
628,237
+91,787
| +17% | +$2.78M | 0.01% | 1186 |
|
|
2021
Q1 | $17M | Sell |
536,450
-132,332
| -20% | -$3.88M | 0.01% | 1255 |
|
|
2020
Q4 | $13.9M | Sell |
668,782
-258,864
| -28% | -$4.83M | 0.01% | 1379 |
|
|
2020
Q3 | $14.4M | Buy |
927,646
+26,993
| +3% | +$465K | 0.01% | 1183 |
|
|
2020
Q2 | $16.5M | Sell |
900,653
-674,705
| -43% | -$11.9M | 0.01% | 1043 |
|
|
2020
Q1 | $24.4M | Buy |
1,575,358
+790,096
| +101% | +$19.1M | 0.02% | 738 |
|
|
2019
Q4 | $23.5M | Buy |
785,262
+141,201
| +22% | +$3.67M | 0.02% | 936 |
|
|
2019
Q3 | $14.1M | Sell |
644,061
-171,523
| -21% | -$3.92M | 0.01% | 1117 |
|
|
2019
Q2 | $20.6M | Buy |
815,584
+176,548
| +28% | +$4.19M | 0.02% | 913 |
|
|
2019
Q1 | $15.8M | Sell |
639,036
-720,506
| -53% | -$17.2M | 0.01% | 989 |
|
|
2018
Q4 | $25.1M | Buy |
1,359,542
+76,582
| +6% | +$1.82M | 0.03% | 673 |
|
|
2018
Q3 | $32.9M | Buy |
1,282,960
+316,168
| +33% | +$7.24M | 0.03% | 609 |
|
|
2018
Q2 | $22.5M | Sell |
966,792
-471,578
| -33% | -$9.75M | 0.02% | 776 |
|
|
2018
Q1 | $22.9M | Buy |
1,438,370
+120,575
| +9% | +$2.24M | 0.02% | 778 |
|
|
2017
Q4 | $27.4M | Buy |
1,317,795
+302,215
| +30% | +$4.79M | 0.02% | 715 |
|
|
2017
Q3 | $14.6M | Buy |
1,015,580
+39,630
| +4% | +$599K | 0.01% | 1025 |
|
|
2017
Q2 | $16.9M | Buy |
975,950
+86,995
| +10% | +$1.04M | 0.02% | 901 |
|
|
2017
Q1 | $9.8M | Sell |
888,955
-36,732
| -4% | -$505K | 0.01% | 1236 |
|
|
2016
Q4 | $13.4M | Buy |
925,687
+79,957
| +9% | +$1.47M | 0.01% | 1034 |
|
|
2016
Q3 | $20.8M | Sell |
845,730
-126,889
| -13% | -$3.28M | 0.02% | 803 |
|
|
2016
Q2 | $19.6M | Buy |
972,619
+322,987
| +50% | +$9.15M | 0.02% | 774 |
|
|
2016
Q1 | $17.1M | Sell |
649,632
-890,764
| -58% | -$65.9M | 0.02% | 796 |
|
|
2015
Q4 | $157M | Buy |
1,540,396
+994,476
| +182% | +$112M | 0.18% | 114 |
|
|
2015
Q3 | $97.4M | Buy |
545,920
+5,810
| +1% | +$1.35M | 0.12% | 177 |
|
|
2015
Q2 | $120M | Sell |
540,110
-13,966
| -3% | -$3.1M | 0.12% | 179 |
|
|
2015
Q1 | $110M | Buy |
554,076
+58,019
| +12% | +$10.3M | 0.11% | 193 |
|
|
2014
Q4 | $71M | Sell |
496,057
-105,036
| -17% | -$14.1M | 0.06% | 323 |
|
|
2014
Q3 | $78.9M | Buy |
601,093
+542
| +0.1% | +$64.6K | 0.06% | 313 |
|
|
2014
Q2 | $75.7M | Buy |
600,551
+156,832
| +35% | +$20M | 0.06% | 319 |
|
|
2014
Q1 | $58.5M | Sell |
443,719
-16,232
| -4% | -$2.22M | 0.06% | 360 |
|
|
2013
Q4 | $54M | Buy |
+459,951
| New | +$50.4M | 0.05% | 384 |
|
Other funds holding BHC
IC
GAM
PC
Credit Suisse's BHC Position: Q1 2024 in Review
Credit Suisse reduced its Bausch Health (BHC) stake by 18% in Q1 2024, selling an estimated $1.05M and leaving 562,172 shares worth $5.96M. The position accounts for 0.01% of the portfolio, ranked #1195.
Credit Suisse first reported a position in BHC in Q4 2013 and has held it in 42 quarters since. The position peaked at $157M in Q4 2015. 237 funds tracked by Wall St. Rank hold BHC as of Q1 2024.
- Credit Suisse held 562,172 shares of Bausch Health worth $5.96M as of Q1 2024.
- Credit Suisse sold 120,146 Bausch Health shares in Q1 2024, an estimated $1.05M.
- Bausch Health made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #1195 holding.
- Credit Suisse first reported a position in Bausch Health in Q4 2013 and has held it in 42 quarters since.
- Credit Suisse's Bausch Health position peaked at $157M in Q4 2015.
- 237 funds tracked by Wall St. Rank held Bausch Health as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.